Dyno Therapeutics | BiotechTV

top of page

ASGCT 2025: Dyno Therapeutics' CEO Eric Kelsic discusses the latest in capsids for CNS, ophthalmology, and neuromuscular conditions

He talks about new capsids Dyno announced at this years' conference and the science behind getting them to specific places in the body....

Company News

2 days ago

Dyno Therapeutics is using AI to develop next generation AAV vectors for gene therapies

Co-Founder & CSO Adrian Veres and Head of Stewardship Tyson Bertmaring describe the shortcomings of wild type AAV that Dyno is trying to...

Company News

Oct 1, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

ASGCT 2025: Dyno Therapeutics' CEO Eric Kelsic discusses the latest in capsids for CNS, ophthalmology, and neuromuscular conditions

Dyno Therapeutics is using AI to develop next generation AAV vectors for gene therapies

Follow BiotechTV

Sponsors

Sponsor Spotlight